Karen K. Xu - Publications

Affiliations: 
2016- Pharmacology University of California, Davis, Davis, CA 

0/19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2022 Gopalan A, Blatchins MA, Xu KK, Altschuler A, Marshall CJ, Hessler DM, Fernandez A, Grant RW. All in the Family: A Qualitative Study of the Early Experiences of Adults with Younger Onset Type 2 Diabetes. Journal of the American Board of Family Medicine : Jabfm. 35: 341-351. PMID 35379721 DOI: 10.3122/jabfm.2022.02.210223  0.01
2022 Xu K, Ramesh K, Huang V, Gurbani SS, Cordova JS, Schreibmann E, Weinberg BD, Sengupta S, Voloschin AD, Holdhoff M, Barker PB, Kleinberg LR, Olson JJ, Shu HG, Shim H. Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma. Tomography (Ann Arbor, Mich.). 8: 688-700. PMID 35314634 DOI: 10.3390/tomography8020057  0.01
2021 Xu KK, Chen KK, Kim E, García-Fernández J, Nauright J, Zhang JJ. Dimensions of Service Quality in Health-Fitness Clubs in China. International Journal of Environmental Research and Public Health. 18. PMID 34682314 DOI: 10.3390/ijerph182010567  0.01
2020 Power N, Ganjisaffar F, Xu K, Perring TM. Effects of Parasitoid Age, Host Egg Age, and Host Egg Freezing on Reproductive Success of Ooencyrtus mirus (Hymenoptera: Encyrtidae) on Bagrada hilaris (Hemiptera: Pentatomidae) Eggs. Environmental Entomology. PMID 33219688 DOI: 10.1093/ee/nvaa150  0.01
2020 Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, et al. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy. PMID 32624405 DOI: 10.1016/j.brachy.2020.05.007  0.01
2020 Eng TY, Abugideiri M, Chen TW, Madden N, Morgan T, Tanenbaum D, Wandrey N, Westergaard S, Xu K. Radiation Therapy for Benign Disease: Keloids, Macular Degeneration, Orbital Pseudotumor, Pterygium, Peyronie Disease, Trigeminal Neuralgia. Hematology/Oncology Clinics of North America. 34: 229-251. PMID 31739946 DOI: 10.1016/j.hoc.2019.09.006  0.01
2020 Eng TY, Abugideiri M, Chen TW, Madden N, Morgan T, Tanenbaum D, Wandrey N, Westergaard S, Xu K. Radiation Therapy for Benign Disease: Arteriovenous Malformations, Desmoid Tumor, Dupuytren Contracture, Graves Ophthalmopathy, Gynecomastia, Heterotopic Ossification, Histiocytosis. Hematology/Oncology Clinics of North America. 34: 205-227. PMID 31739945 DOI: 10.1016/j.hoc.2019.09.005  0.01
2019 Kim JH, Yang B, Tedesco A, Lebig EGD, Ruegger PM, Xu K, Borneman J, Martins-Green M. High Levels of Oxidative Stress and Skin Microbiome are Critical for Initiation and Development of Chronic Wounds in Diabetic Mice. Scientific Reports. 9: 19318. PMID 31848388 DOI: 10.1038/S41598-019-55644-3  0.01
2018 Meng C, Zhou J, Papaneri A, Peddada T, Xu K, Cui G. Spectrally Resolved Fiber Photometry for Multi-component Analysis of Brain Circuits. Neuron. PMID 29731250 DOI: 10.1016/J.Neuron.2018.04.012  0.01
2017 Quan K, Sutera P, Xu K, Bernard ME, Burton SA, Wegner RE, Zeh H, Bahary N, Stoller R, Heron DE. Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma. Practical Radiation Oncology. PMID 29291966 DOI: 10.1016/j.prro.2017.10.001  0.01
2017 Munir I, Fargo R, Garrison R, Yang A, Cheng A, Kang I, Motabar A, Xu K, Loo LK, Kim DI. Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis. Bmj Open Diabetes Research & Care. 5: e000395. PMID 28878933 DOI: 10.1136/bmjdrc-2017-000395  0.01
2017 Gall T, Valkanas E, Bello C, Markello T, Adams C, Bone WP, Brandt AJ, Brazill JM, Carmichael L, Davids M, Davis J, Diaz-Perez Z, Draper D, Elson J, Flynn ED, ... ... Xu K, et al. Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience. Frontiers in Medicine. 4: 62. PMID 28603714 DOI: 10.3389/Fmed.2017.00062  0.01
2016 Lee EM, Xu K, Mosbrook E, Links A, Guzman J, Adams DR, Flynn E, Valkanas E, Toro C, Tifft CJ, Boerkoel CF, Gahl WA, Sincan M. Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27253732 DOI: 10.1038/Gim.2016.47  0.01
2016 Jiang W, Conkle JL, Luo Y, Li J, Xu K, Gan JJ. Occurrence, Distribution and Accumulation of Pesticides in Exterior Residential Areas. Environmental Science & Technology. PMID 27174594 DOI: 10.1021/Acs.Est.6B01396  0.01
2016 Shinde A, Berhane H, Rhieu BH, Kalash R, Xu K, Goff J, Epperly MW, Franicola D, Zhang X, Dixon T, Shields D, Wang H, Wipf P, Parmar K, Guinan E, et al. Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice. Radiation Research. PMID 26789701 DOI: 10.1667/Rr14035.1  0.01
2014 Berhane H, Shinde A, Kalash R, Xu K, Epperly MW, Goff J, Franicola D, Zhang X, Dixon T, Shields D, Wang H, Wipf P, Li S, Gao X, Greenberger JS. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039. Radiation Research. 182: 35-49. PMID 24932534 DOI: 10.1667/Rr13633.1  0.01
2009 Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Teneurin C-terminal associated peptide (TCAP)-1 attenuates corticotropin-releasing factor (CRF)-induced c-Fos expression in the limbic system and modulates anxiety behavior in male Wistar rats. Behavioural Brain Research. 201: 198-206. PMID 19428634 DOI: 10.1016/J.Bbr.2009.02.013  0.01
2008 Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety. Behavioural Brain Research. 188: 195-200. PMID 18082275 DOI: 10.1016/J.Bbr.2007.10.032  0.01
2007 Al Chawaf A, Xu K, Tan L, Vaccarino FJ, Lovejoy DA, Rotzinger S. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1). Peptides. 28: 1406-15. PMID 17644218 DOI: 10.1016/J.Peptides.2007.05.014  0.01
Hide low-probability matches.